-
Tris(2-carboxyethyl) Phosphine Hydrochloride in Protein Dige
2026-05-30
Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein digestion and redox workflows with its robust, odorless, and thiol-free disulfide bond reduction. Its unmatched stability and versatility streamline advanced assays, supporting breakthroughs in proteomics and DNA-protein crosslink analysis.
-
5X Protein Loading Buffer (Reducing) for SDS-PAGE Applicatio
2026-05-29
5X Protein Loading Buffer (Reducing) streamlines protein sample preparation for SDS-PAGE by ensuring complete denaturation and reduction of disulfide bonds. It is suited for workflows requiring reliable protein molecular weight separation but is not appropriate for applications where non-reducing conditions or native conformation are required.
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor Pr
2026-05-29
Wang et al. (2018) systematically dissected the cellular entry mechanism of genotype III grass carp reovirus (GCRV104), revealing a critical dependence on clathrin-mediated, pH- and dynamin-dependent endocytosis. Their pharmacological inhibitor analysis also clarified that actin cytoskeleton disruption does not impede GCRV104 entry, refining the mechanistic understanding of aquareovirus infection and informing antiviral research strategies.
-
Fibroblast Heterogeneity Drives Airway Repair After Surgery
2026-05-28
This study leverages single-cell RNA sequencing to reveal how distinct fibroblast subsets coordinate the repair response to surgery-induced stress in airway reconstruction. The findings identify key fibroblast populations and signaling pathways that underlie tissue remodeling and complications, offering new perspectives for regenerative medicine and fibrosis research.
-
AP20187: Benchmarking a Chemical Inducer of Dimerization
2026-05-28
AP20187 is a synthetic, cell-permeable chemical inducer of dimerization that enables precise control of protein-protein interactions in conditional gene expression systems. Its high solubility and validated in vivo efficacy make it a reference standard for regulated cell therapy and metabolic research.
-
Viral Degradation of RIPK3 Regulates Necroptosis and Inflamm
2026-05-27
Liu et al. identify a family of orthopoxvirus proteins that target the host necroptosis adaptor RIPK3 for proteasome-mediated degradation, revealing a crucial mechanism by which viruses modulate inflammation and pathogenesis. These findings inform future research on host-pathogen interactions and ubiquitin-proteasome pathway regulation.
-
Biochemical Characterization of FANCJ Helicase in G4 DNA Res
2026-05-27
This study provides a comprehensive protocol for purifying and characterizing human FANCJ, a DNA helicase critical for resolving G-quadruplex (G4) DNA structures linked to genomic stability and disease. The methodological clarity and mechanistic insights enable researchers to better dissect FANCJ’s multifaceted roles in DNA repair pathways.
-
Discovery of Novel 14-3-3 Binding Proteins ATG9A and PTOV1 i
2026-05-26
This study identifies ATG9A and PTOV1 as previously unrecognized 14-3-3 binding partners, elucidating their mechanistic involvement in autophagy regulation and oncogenic stability, respectively. The findings provide new molecular insights into cancer progression and highlight potential therapeutic targets within 14-3-3 mediated signaling pathways.
-
RBBP8 Modulates UPR-Driven Liver Damage via Protein Synthesi
2026-05-26
A recent study employs genome-wide CRISPR screening to reveal RBBP8 as a key regulator of the unfolded protein response (UPR) and liver damage through control of ATF4-mediated protein synthesis. These findings deepen our understanding of ER stress adaptation and suggest new therapeutic avenues for liver disease.
-
Viral-Induced RIPK3 Degradation Regulates Necroptosis and In
2026-05-25
This study reveals how orthopoxviruses encode a viral inducer of RIPK3 degradation (vIRD), enabling targeted proteasome-mediated destruction of the necroptosis adaptor RIPK3 to modulate host inflammation and viral pathogenesis. These findings provide a mechanistic framework for studying proteasome function in antiviral immunity and highlight opportunities for precise manipulation of the ubiquitin-proteasome axis in disease models.
-
PDI Inhibition Enhances Panobinostat Efficacy in Multiple My
2026-05-25
The reference study demonstrates that combining the PDI inhibitor LTI6426 with panobinostat significantly improves anti-myeloma efficacy using both in vitro and in vivo models. This combination enables dose reduction of panobinostat, potentially reducing toxicity and highlighting ER stress pathway biomarkers as pharmacodynamic indicators.
-
InstaBlue Protein Stain Solution: Reliable, Rapid Protein Vi
2026-05-24
This article addresses persistent laboratory challenges in protein quantification and gel analysis, highlighting how InstaBlue Protein Stain Solution (SKU B8226) delivers sensitive, reproducible results with minimal workflow disruption. By grounding recommendations in published protocols and direct product data, bench scientists gain actionable strategies for optimizing protein electrophoresis analysis and ensuring downstream compatibility.
-
Nanobody Swapping Enhances Precision Targeting of AAV Vector
2026-05-23
This study introduces an efficient strategy for redirecting adeno-associated virus (AAV) tropism through precise nanobody insertion at newly identified capsid hotspots. By enabling modular swapping of nanobodies, the approach advances cell-type-specific gene delivery with minimal off-target effects, offering significant implications for precision gene therapy.
-
Cl-Amidine trifluoroacetate salt: Optimizing PAD4 Inhibition
2026-05-22
Cl-Amidine (trifluoroacetate salt) enables precise, selective inhibition of PAD4, unlocking powerful experimental control in cancer and immune research. This guide translates cutting-edge findings into actionable protocols, troubleshooting, and advanced use-cases for maximum data quality.
-
CB-5083: Optimizing p97 Inhibitor Workflows for Tumor Models
2026-05-22
CB-5083 enables precise, reproducible disruption of protein homeostasis and apoptosis induction in cancer models, making it an essential tool for translational oncology research. This guide covers experimental workflows, troubleshooting, and new insights from ER lipid-protein regulation studies to help researchers maximize the impact of p97 inhibition.